Hepatitis C News

Clinical pharmacist-delivered hepatitis C virus therapy yields high rates of SVR, according to findings published in Open Forum Infectious Diseases.

Intent Solutions announced a partnership with the University of Kentucky in a $15 million federal grant program aimed at eliminating hepatitis C in an eastern Kentucky county that has particularly high rates of chronic infection, according to a press release.

The pangenotypic direct-acting antiviral Mavyret demonstrated 100% sustained virologic response in adolescent patients aged 12 years to 17 years with a safety profile consistent with adult patients, according results from part one of the DORA study.

Providing direct acting antivirals, or DAAs, for hepatitis C virus infection in primary care settings significantly increases treatment uptake and cure rates in people who inject drugs, or PWID, suggesting HCV treatment should be available in primary care, researchers found.

Compared with the general U.S. population, veterans with PTSD appeared at higher risk for death by suicide, accidental injury and viral hepatitis, according to data published in American Journal of Preventive Medicine.

Louisiana Governor John Bel Edwards, Secretary Rebekah Gee of the Louisiana Department of Health, Secretary James LeBlanc of the Louisiana Department of Corrections, and Asegua Therapeutics have agreed on a model to implement the health department’s innovative payment model for hepatitis C treatment, according to a press release.

Treatment with Sovaldi and ribavirin was well-tolerated and highly effective in children aged 3 years to less than 12 years in pediatric patients with hepatitis C genotype 2 or genotype 3, according to a study published in Hepatology.

Allergan will be acquired by AbbVie for approximately $63 billion in cash and stock, the two companies announced in a press release.

In a recently published commentary, Chelsea Elwood, MD, from the University of British Columbia, and colleagues advised that Canadian guidelines should recommend universal screening for hepatitis C in pregnant women as they do for hepatitis B and HIV to reduce the risk for vertical transmission.

It was my first week of intern year, in the medical ICU. He presented in extremis and died within 90 minutes. He was reportedly bitten by his dog 3 days prior. I remember leaving the MICU in tears, overcome with emotion, feelings of guilt and helplessness, wishing I could have changed his outcome. When his admission blood cultures later grew Capnocytophaga canimorsus, I was intrigued. I was unfamiliar with the organism at the time and yearned to learn more. Henceforth, I was “hooked on ID,” forever.